Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Brain Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05146219
What this trial is testing

Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation

Who this might be right for
NSCLCEGFR Activating MutationBrain Metastases+1 more
TYK Medicines, Inc 29
Testing effectiveness (Phase 2)Ended earlyNCT01497665
What this trial is testing

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
Angiochem Inc 16
Not applicableUnknownNCT04778800
What this trial is testing

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Who this might be right for
NSCLCBrain MetastasesLeptomeningeal Metastasis
Henan Cancer Hospital 60
Not applicableActive Not RecruitingNCT05341739
What this trial is testing

A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases

Who this might be right for
Brain Metastases, Adult
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 20
Testing effectiveness (Phase 2)Ended earlyNCT03331601
What this trial is testing

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

Who this might be right for
CarcinomaReceptor, ErbB-2
Universitair Ziekenhuis Brussel 7
Large-scale testing (Phase 3)Looking for participantsNCT05961644
What this trial is testing

Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).

Who this might be right for
Multiple Sclerosis, Secondary ProgressiveMultiple Sclerosis
Institute of Psychiatry and Neurology, Warsaw 188
Not applicableNot Yet RecruitingNCT07497945
What this trial is testing

Optic Nerve Sheath Diameter for Predicting Post-Dural Puncture Headache in Cesarean Section Patients

Who this might be right for
Post Dural Puncture Headache
Kocaeli University 220
Large-scale testing (Phase 3)Active Not RecruitingNCT05438212
What this trial is testing

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the Brain
NRG Oncology 237
Not applicableStudy completedNCT02824107
What this trial is testing

Psychosocial Risk Factors in Stroke and Myocardial Infarction

Who this might be right for
Myocardial InfarctionStroke
Centre Hospitalier Universitaire Dijon 294
Not applicableUnknownNCT05376163
What this trial is testing

Validity of Headache Disability Index

Who this might be right for
Neck PainHeadacheCervical Pain
Hacettepe University 250
Testing effectiveness (Phase 2)UnknownNCT04801342
What this trial is testing

Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm to Brain
National Taiwan University Hospital 72
Early research (Phase 1)Ended earlyNCT01950195
What this trial is testing

SRS (Stereotactic Radiosurgery) Plus Ipilimumab

Who this might be right for
Newly Diagnosed Melanoma Metastases in the Brain and Spine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Large-scale testing (Phase 3)Active Not RecruitingNCT00950001
What this trial is testing

Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 132
Large-scale testing (Phase 3)Study completedNCT04768075
What this trial is testing

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Guangdong Association of Clinical Trials 60
Not applicableEnded earlyNCT01363557
What this trial is testing

Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis

Who this might be right for
EGFR-mutated Lung AdenocarcinomaBrain Metastasis
Assistance Publique - Hôpitaux de Paris 1
Not applicableStudy completedNCT05095766
What this trial is testing

Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis Diagnosis

Who this might be right for
Brain Metastases, Adult
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 40
Not applicableStudy completedNCT01682967
What this trial is testing

Alteration in Hearing Following Accidental Dural Puncture. A Study in Parturients

Who this might be right for
Parturients in Labour
Örebro University, Sweden 21
Not applicableUnknownNCT01836848
What this trial is testing

Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG

Who this might be right for
Subarachnoid Hemorrhage, AneurysmalIntracerebral Hemorrhage (ICH)Traumatic Brain Injury
University of Cologne 30
Testing effectiveness (Phase 2)UnknownNCT03412955
What this trial is testing

A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes

Who this might be right for
Breast Cancer
Tan Tock Seng Hospital 14
Not applicableStudy completedNCT01532726
What this trial is testing

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Who this might be right for
Epilepsy
Bial - Portela C S.A. 56
Next Page